Authenticity In An Automated World: Surprising Guidance From Healthcare

A young healthcare working speaking with another woman about her age

Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t sound quite human and videos that could be deceptive altered deepfakes, consumers increasingly have questions about what is real. In a world of growing automation…

Read More

Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program

Happy Pride Month logo

By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education for healthcare professionals. While these initiatives usually address “underrepresented communities,” in practice, they often refer to increasing participation among racial and ethnic groups. During Pride…

Read More

Reverba Maintains Commitment to Patient Data Security and Privacy with Ongoing SOC 2®, Type II Certification

SOC 2 certification aligns Reverba with world-class organizations achieving the highest level of security and compliance for data management for service organizations – SEATTLE – April 20, 2023 – Reverba, a leading global patient engagement company, announces that it has successfully reaffirmed the Service Organization Control (SOC) 2, Type II certification for 2023, completing this important…

Read More

The Patient Voice: Industry and Advocates Speak in Harmony

A video conference call

By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering patient advocacy group. At the Global Innovation in Patient Advocacy conference, one theme echoed throughout multiple presentations by patient advocates and industry representatives alike: it’s important to…

Read More

How Can We Have More Successful Rare Disease Trials?

Rare Disease Day ribbon

By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each of these estimated 5,000 to 7,000 or more rare diseases affects a relatively small number of individuals, the impact on those patients’ lives is significant.…

Read More

Patient Engagement: What Matters Most in 2023

Young female doctors talking

By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years of global pandemic. Yes, many events were in-person once again and lots of companies began pushing for people to return to the office, but have…

Read More

Reverba Celebrates 20 Years of Amplifying Patient Voices

– 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the way in patient engagement solutions for life sciences companies – SEATTLE – October 10, 2022 – Reverba, a leading global patient engagement company, announces the celebration of its 20th Anniversary. This marks two decades of empowering people to share their…

Read More

It’s Our Anniversary: 20 Years, 20 Reasons to Believe

A lit sparkler

By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of flash-in-the-pan startups, building a company that doesn’t just last – but one that grows, thrives, and defines the industry it’s a part of – is…

Read More